Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arvind Mathur

Showing results (61-70 of 148) with videos related to

Pageof 15
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 18, 2004
The synthesis and evaluation of [2.2.1]-bicycloazahydantoins as androgen receptor antagonistsAaron Balog, Mark E Salvati, Weifang Shan, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2007
Novel C-5 aminomethyl pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinasesHarold Mastalerz, Ming Chang, Ashvinikumar Gavai, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2019
Design, synthesis and biological evaluation of phenol-linked uncialamycin antibody-drug conjugatesYam B Poudel, Chetana Rao, Srikanth Kotapati, et al.
Bioorganic & Medicinal Chemistry Letters|August 1, 2007
Synthesis and SAR of p38alpha MAP kinase inhibitors based on heterobicyclic scaffoldsT G Murali Dhar, Stephen T Wrobleski, Shuqun Lin, et al.
Journal of Medicinal Chemistry|October 1, 2025
Beyond Bioisosteres: Impact of Replacing a Benzene Ring with sp<sup>3</sup>-Rich Three-Dimensional Saturated Bridged Bicyclic Match Pairs on Biotransformation, Metabolic Stability, and Other ADME ProfilesShruti Surendran, Sivashankaran Raju, Naveen Kalyani, et al.
Bioorganic & Medicinal Chemistry Letters|February 28, 2012
Identification and optimization of small molecule antagonists of vasoactive intestinal peptide receptor-1 (VIPR1)Lalgudi S Harikrishnan, Neelam Srivastava, Lauren E Kayser, et al.
The Journal of Organic Chemistry|December 3, 2025
Desymmetrization of <i>meso</i>-Anhydride Enabled Enantioselective Synthesis of (-)-7-(Bromomethylene)-3-amidobicyclo[2.2.1]heptane-2-carboxamide, a Scaffold for Divergent Drug Discovery SynthesisJianqing Li, Subramaniam Krishnananthan, Daniel Smith, et al.
Journal of Medicinal Chemistry|August 5, 2024
Atropisomerism Observed in Galactose-Based Monosaccharide Inhibitors of Galectin-3 Comprising 2-Methyl-4-phenyl-2,4-dihydro-3<i>H</i>-1,2,4-triazole-3-thioneDavid S Yoon, Chunjian Liu, Prasada Rao Jalagam, et al.
ACS Medicinal Chemistry Letters|November 19, 2021
BMS-813160: A Potent CCR2 and CCR5 Dual Antagonist Selected as a Clinical CandidateRobert J Cherney, Prakash Anjanappa, Kumaravel Selvakumar, et al.
Journal of Medicinal Chemistry|December 28, 2002
Biphenylsulfonamide endothelin receptor antagonists. 4. Discovery of N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]- 2-yl]methyl]-N,3,3-trimethylbutanamide (BMS-207940), a highly potent and orally active ET(A) selective antagonistNatesan Murugesan, Zhengxiang Gu, Steven Spergel, et al.
Pageof 15

Showing results (61-70 of 148) with videos related to

Sort By:
Pageof 15
Bioorganic & Medicinal Chemistry Letters|November 18, 2004
The synthesis and evaluation of [2.2.1]-bicycloazahydantoins as androgen receptor antagonistsAaron Balog, Mark E Salvati, Weifang Shan, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2007
Novel C-5 aminomethyl pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinasesHarold Mastalerz, Ming Chang, Ashvinikumar Gavai, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 2019
Design, synthesis and biological evaluation of phenol-linked uncialamycin antibody-drug conjugatesYam B Poudel, Chetana Rao, Srikanth Kotapati, et al.
Bioorganic & Medicinal Chemistry Letters|August 1, 2007
Synthesis and SAR of p38alpha MAP kinase inhibitors based on heterobicyclic scaffoldsT G Murali Dhar, Stephen T Wrobleski, Shuqun Lin, et al.
Journal of Medicinal Chemistry|October 1, 2025
Beyond Bioisosteres: Impact of Replacing a Benzene Ring with sp<sup>3</sup>-Rich Three-Dimensional Saturated Bridged Bicyclic Match Pairs on Biotransformation, Metabolic Stability, and Other ADME ProfilesShruti Surendran, Sivashankaran Raju, Naveen Kalyani, et al.
Bioorganic & Medicinal Chemistry Letters|February 28, 2012
Identification and optimization of small molecule antagonists of vasoactive intestinal peptide receptor-1 (VIPR1)Lalgudi S Harikrishnan, Neelam Srivastava, Lauren E Kayser, et al.
The Journal of Organic Chemistry|December 3, 2025
Desymmetrization of <i>meso</i>-Anhydride Enabled Enantioselective Synthesis of (-)-7-(Bromomethylene)-3-amidobicyclo[2.2.1]heptane-2-carboxamide, a Scaffold for Divergent Drug Discovery SynthesisJianqing Li, Subramaniam Krishnananthan, Daniel Smith, et al.
Journal of Medicinal Chemistry|August 5, 2024
Atropisomerism Observed in Galactose-Based Monosaccharide Inhibitors of Galectin-3 Comprising 2-Methyl-4-phenyl-2,4-dihydro-3<i>H</i>-1,2,4-triazole-3-thioneDavid S Yoon, Chunjian Liu, Prasada Rao Jalagam, et al.
ACS Medicinal Chemistry Letters|November 19, 2021
BMS-813160: A Potent CCR2 and CCR5 Dual Antagonist Selected as a Clinical CandidateRobert J Cherney, Prakash Anjanappa, Kumaravel Selvakumar, et al.
Journal of Medicinal Chemistry|December 28, 2002
Biphenylsulfonamide endothelin receptor antagonists. 4. Discovery of N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]- 2-yl]methyl]-N,3,3-trimethylbutanamide (BMS-207940), a highly potent and orally active ET(A) selective antagonistNatesan Murugesan, Zhengxiang Gu, Steven Spergel, et al.
Pageof 15